The Briefing: Brandy Melville vs. Shein -When Copying Photos Isn't Trademark Infringement
Hemant Gupta Bridges the Gap Between Cutting-Edge Technology and Intellectual Property Protection
AI In the Public Interest: Authorship & Copyright in the Age of AI
The Briefing: Pepperdine’s Trademark Claim Against Netflix in “Running Point” Case Goes Under For Good
Episode 421 -- The Dangers of AI Mistakes
EEO-1 Reports, Remote Work, and Non-Compete Restrictions in Tennessee - Employment Law This Week®
The Briefing: UMG v. Quince: When Trending Audio Becomes Copyright Infringement
Unexpected Paths to IP Law with Kevin MacDonald
New Preorder Patent Owner Rights in Ex Parte Reexamination — Patents: Post-Grant Podcast
The Briefing: Documentary Fair Use After Warhol: The Tenth Circuit Gets It Right
Words Matter: How to Draft Arbitration Agreements That Hold Up in Court - Employment Law This Week®
SkadBytes Podcast | AI Regulation: EU and UK Update and What It Means in Practice
The Briefing: Frida Kahlo vs. The 11th Circuit - A Warning for IP Owners Everywhere
Navigating ICE’s Updated I-9 Audit Guidelines: What Employers Need to Know
At the Intersection of Biotech and AI with Janice Vatland
Podcast - De genérica a icónica: El glow up de una marca
JONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the U.S. Courts
How Did James Bond Spark a 50-Year Legal War Over Who Owns 007? — No Infringement Intended Podcast
Episode 406 -- AI Risks and Compliance: Building a Governance Framework
The Briefing: Taylor Swift, Trademark Law, and the Fight Over ‘Life of a Showgirl’
Artificial intelligence (AI) is now a part of U.S. design patent examination, but not in the way some practitioners may expect. The latest public USPTO materials do not identify a new, post-DesignVision AI tool dedicated to...more
Kilpatrick partner Ted Davis spoke recently on recent developments in U.S. trademark and unfair competition law as part of Kilpatrick's "IP Innovations" series. That presentation addressed, inter alia, the following topics:...more
The Director issued a precedential discretionary denial on the ground that a foreign government entity was an undisclosed real party in interest(“RPI”). The ruling extended Return Mail, Inc. v. United States Postal Service,...more
AI governance is often discussed through the lens of policies, frameworks, and responsible AI principles. Those tools matter, but they are not where many of the most important AI decisions are actually being made. In...more
AI is transforming drug discovery faster than deal structures can adapt. Traditional licensing frameworks were built for linear innovation: researcher invents, institution owns, licensee commercializes. AI shatters that model...more
Two recent opinions from the District of Delaware underscore a familiar, but increasingly enforced, principle: courts will closely scrutinize the factual basis for damages opinions in patent cases. Although neither decision...more
Much legal discussion about artificial intelligence (AI) focuses on whether using unauthorized content to teach AI is transformative, and therefore, not infringement, or the rights and liabilities of AI-created content. What...more
The Patent Office has made the Streamlined Claim Set Pilot Program a little easier to use by waiving the $150 petition fee ($60 for Small Entity) that would otherwise apply. This program offers an attractive alternative to...more
Most services agreements for vendor-provided technology services contain standard provisions allowing vendors to use customer data and data generated through the provision of services to improve and enhance service offerings....more
Recently, social media personality Pattie Gonia shared a video with her more than 2 million Instagram and TikTok followers to draw attention to a lawsuit by clothing brand Patagonia filed against her in January....more
In recent weeks, Congress and the Administration have escalated scrutiny of China-linked biotechnology, pharmaceutical development, and related intellectual property. The developments below signal that the landscape for...more
In a unanimous decision of June 4, 2026 in Hikma Pharmaceutical USA Inc. v. Amarin Pharma Inc., authored by Justice Jackson, the Supreme Court clarified the pleading requirements for claims of induced patent...more
In the recent ruling in Hikma Pharmaceuticals v. Amarin Pharma, No. 24–889., the U.S. Supreme Court applied its pleading standards established in the Twombly and Iqbal line of cases and unanimously held plaintiff, Amarin...more
Our Patent Case Summaries provide a weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial...more
Operation Bluebird, Inc. (“Bluebird”) and X Corp. are locked in a dispute over the future of the Twitter brand, stemming from the platform’s rebrand from “Twitter” to “X” in 2023. The TMCA covered the rebrand....more
When a company files for bankruptcy, Section 541 of the Bankruptcy Code creates a bankruptcy “estate” comprised of virtually all its interests in property. The estate includes the debtor’s interests in tangible assets, like...more
In the first installment of patents and politics, we reported that the United States was potentially entering into an era of IP policy driven by President Trump’s America First rhetoric. In March, Mr. John Squires,...more
AGI SURETRACK LLC v. FARMERS EDGE INC. - Before Moore, Mayer, and Lourie. Appeal from the District of Nebraska. Patents claiming data collection, processing, and transmission using generic computer components are...more
In this episode of The Briefing, Weintraub Tobin partners Scott Hervey and Tara Sattler discuss the court’s ruling, where Brandy Melville’s trademark claims fell short, and whether a different trademark argument could have...more
The first quarter of 2026 saw several meaningful Section 337 decisions from the U.S. International Trade Commission (“Commission”). These decisions addressed the domestic industry requirement, the impact of redesigned...more
Recently, the Federal Circuit affirmed the Eastern District of Michigan’s ruling that Ford Motor Company (“Ford”) misappropriated Versata Software Inc.’s (“Versata”) trade secrets and breached a software licensing agreement. ...more
The Supreme Court just handed generic manufacturers – and really, all patent defendants – a major win in Hikma v. Amarin, unanimously reversing the Federal Circuit and tightening the standard for induced infringement under §...more
A medical device company had an NDA. They had a jury award of more than $17 million. They had a permanent injunction against their competitor. The Federal Circuit reversed almost all of it....more
On June 8, 2026, Alvotech announced that the FDA accepted for review its abbreviated Biologics License Application (“aBLA”) for AVT16, a proposed interchangeable biosimilar to Takeda’s Entyvio® (vedolizumab). AVT16 is the...more
On June 2, 2026, the White House issued the Order which announces that it is “the policy of the United States to promote AI innovation and security by working collaboratively with the private sector to modernize government...more